Newsroom Hospital for Special Surgery (Spiera)
Filter by year
2024
January
25,
2024
|
09:12 AM
America/New_York
The Rheumatologist featuring Robert F. Spiera, MD
Read more
January
25,
2024
|
09:07 AM
America/New_York
The Rheumatologist featuring Robert F. Spiera, MD
Read more
2023
November
14,
2023
|
12:05 PM
America/New_York
At this year’s American College of Rheumatology (ACR) annual meeting, HSS presented a number of important studies focused on reproductive health for patients with systemic lupus erythematosus, rheumatoid arthritis, and other rheumatic diseases, …
Read more
October
24,
2023
|
11:16 AM
America/New_York
(New York, New York) – The New England Journal of Medicine published positive results from a Phase 3 international clinical trial demonstrating the efficacy of sarilumab (Kevzara®) in adult patients with refractory polymyalgia rheumatica (PMR). …
Read more
2022
December
02,
2022
|
10:54 AM
America/New_York
American College of Rheumatology featuring Robert F. Spiera, MD
Read more
2021
June
05,
2021
|
17:36 PM
America/New_York
Healio Rheumatology featuring Robert F. Spiera, MD
Read more
April
08,
2021
|
19:49 PM
America/New_York
Healio Rheumatology featuring Robert F. Spiera, MD
Read more
2020
September
28,
2020
|
15:36 PM
America/New_York
MedPage Today featuring Robert F. Spiera, MD
Read more
June
15,
2020
|
10:29 AM
America/New_York
The Rheumatologist featuring Robert F. Spiera, MD
Read more
2019
December
24,
2019
|
09:12 AM
America/New_York
CreakyJoints featuring Lindsay S. Lally, MD, and Robert F. Spiera, MD
Read more
December
16,
2019
|
12:33 PM
America/New_York
MedPage Today featuring Robert F. Spiera, MD
Read more
September
24,
2019
|
11:07 AM
America/New_York
An international, multicenter phase II clinical trial is evaluating the efficacy and safety of mavrilimumab co-administered with a 26-week corticosteroid taper in patients with giant cell arteritis (GCA). The study is sponsored by Kiniksa …
Read more
March
20,
2019
|
08:00 AM
America/New_York
Hospital for Special Surgery is evaluating a novel therapeutic approach for diffuse cutaneous systemic sclerosis (dcSSc), one of the most serious, potentially disabling and life-threatening rheumatic diseases. The double-blind, randomized, …
Read more
2018
November
19,
2018
|
07:00 AM
America/New_York
Robert F. Spiera, MD, rheumatologist at HSS, is interviewed at the annual ACR conference by MedPage Today talking about the study that he presented on the safety and efficacy of lenabasum in diffuse scleroderma patients.
He explains how his …
Read more
August
08,
2018
|
07:00 AM
America/New_York
The Rheumatologist published a feature article on rheumatologists whose children followed in their footsteps to practice medicine and interviewed HSS rheumatologist Robert F. Spiera, MD, who was influenced by his father Harry Spiera, MD, to become a …
Read more
June
21,
2018
|
07:00 AM
America/New_York
Scleroderma News reported on a study that found that lenabasum, a potential treatment of diffuse cutaneous scleroderma, was shown to be safe and beneficial for patients during a Phase 2 clinical trial.
HSS rheumatologist Robert F. Spiera, MD, the …
Read more
May
18,
2018
|
07:00 AM
America/New_York
Rheumatology Advisor interviewed HSS rheumatologist Robert F. Spiera, MD, about risk factors and treatment strategies for pulmonary arterial hypertension (PAH) in patients with systemic sclerosis (SSc).
"PAH is an important complication of SSc, and …
Read more
May
17,
2018
|
07:00 AM
America/New_York
Scleroderma News highlighted a study that found that lenabasum, a potential treatment of diffuse cutaneous scleroderma, was shown to be safe, well-tolerated and beneficial for patients.
HSS rheumatologist Robert F. Spiera, MD, the trial's principal …
Read more
January
03,
2018
|
07:00 AM
America/New_York
Medscape interviewed HSS rheumatologists Robert F. Spiera, MD and Susan M. Goodman, MD about their research presented at the 2017 American College of Rheumatology (ACR) Annual Meeting.
Dr. Goodman gave several presentations about social factors, …
Read more
